Assessing and managing risks arising from exposure to endocrine-active chemicals

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 11, Issue 3-4, 2008, Pages 351-372

  Phillips, Karen P ^a   Foster, Warren G ^b,c   Leiss, William ^a   Sahni, Vanita ^a   Karyakina, Nataliya ^a   Turner, Michelle C ^a   Kacew, Sam ^a   Krewski, Daniel ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Centre for Reproductive Care   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE INHIBITOR; BIOLOGICAL MARKER; ENDOCRINE DISRUPTOR; ESTROGEN; RECEPTOR; STEROID;

CANADA; CHEMICAL STRUCTURE; DOSE RESPONSE; ECOLOGY; EUROPE; EXPOSURE; HAZARD ASSESSMENT; HEALTH CARE POLICY; HEALTH HAZARD; HORMESIS; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; NONHUMAN; POPULATION RESEARCH; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TOXICOGENETICS; UNITED STATES;

CANADA; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EUROPEAN UNION; HUMANS; RISK ASSESSMENT; UNITED STATES;

EID: 41349104706     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937400701876657     Document Type: Review

References (199)

1. Andersen, M. E., Yang, R. S. H., French, C. T., Chubb, L. S., and Dennison, J. E. 2002. Molecular circuits, biological switches, and nonlinear dose-response relationships. Environ. Health Perspect. 110(Suppl. 6):971-978.
2. Andersen, M. E., and Dennison, J. E. 2001. Mode of action and tissue dosimetry in current and future risk assessments. Sci. Total Environ. 274:3-14.
3. Andersen, M. E., and Barton, H. A. 1999. Biological regulation of hormone-receptor complex concentrations in relation to dose-response assessments for endocrine-active compounds. Toxicol. Sci. 48:38-50.
4. Ankley, G. T., Mihaich, E., Stahl, R., Tillitt, D., Colborn, T., McMaster, S., Miller, R., Bantle, J., Campbell, P., Denslow, N., Dickerson, R., Folmar, L., Fry, M., Geisy, J., Gray, L. E., Guiney, P., Hutchinson, T., Kennedy, S., Kramer, V., LeBlanc, G., Mayes, M., Nimrod, A., Patino, R., Peterson, R., Purdy, R., Ringer, T., Touart, L., Van Der Kraak, G., and Zacharewski, T. 1998. Overview of a workshop on screening methods for detecting potential (anti-) estrogenic/androgenic chemicals in wildlife. Environ. Toxicol. Chem. 17:68-87.
5. Ashby, J. 2000. Endocrine disruption: Lessons learned. Environ. Health Perspect. 108:A206.
6. Ayotte, P., Muckle, G., Jacobson, J. L., Jacobson, S. W., and Dewailly, É. 2003. Assessment of pre- and postnatal exposure to polychlorinated biphenyls: Lessons from the Inuit cohort study. Environ. Health Perspect. 111:1253-1258.
7. Berlin, C. M., Kacew, S., Lawrence, R., LaKind, J. S., and Campbell, R. 2002. Criteria for chemical selection for programs on human milk surveillance and research for environmental chemicals. J. Toxicol. Environ. Health A 65:1839-1851.
8. Bitman, J., Cecil, H. C., Harris, S. J., and Fries, G. F. 1968. Estrogenic activity of o,p′-DDT in the mammalian uterus and avian oviduct. Science 162:371-372.
9. Blanco, G. A., and Cooper, E. L. 2004. Immune systems, geographic information systems(GIS), environment and health impacts. J. Toxicol. Environ. Health B 7:465-480.
10. Blettner, M., Sauerbrei, W., Schlehofer, B., Scheuchenpflug, T., and Friedenreich, C. 1999. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int. J. Epidemiol. 28:1-9.
11. Bowers, W. J., Nakai, J. S., Chu, I., Wade, M. G., Moir, D., Yagminas, A., Gill, S., Pulido, O., and Meuller, R. 2004. Early developmental neurotoxicity of a PCB/organochlorine mixture in rodents after gestational and lactational exposure. Toxicol. Sci. 77:51-62.
12. Botella, B., Crespo, J., Rivas, A., Cerrillo, I., Olea-Serrano M. F., and Olea, N. 2004. Exposure of women to organochlorine pesticides in Southern Spain. Environ. Res. 96:34-40.
13. Brody, J. G., Aschengrau, A., McKelvey, W., Rudel, R. A., Swartz, C. H., and Kennedy, T. 2004. Breast cancer risk and historical exposure to pesticides from wide-area applications assessed with GIS. Environ. Health Perspect. 112:889-897.
14. Brouwer, A., and Van den Berg, K. J. 1986. Binding of a metabolite of 3,3′4,4′-tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxine. Toxicol. Appl. Pharmacol. 85:301-312.
15. Calabrese, E. J. 2005. Historical blunders: How toxicology got the dose-response relationship half right. Cell. Mol. Biol. (Noisy-le-grand) 51:643-654.
16. Calabrese, E. J., and Baldwin, L. A. 1994. A toxicological basis to derive a generic interspecies uncertainty factor. Environ. Health Perspect. 102:14-17.
17. Calabrese, E. J., and Baldwin, L. A. 2003. Hormesis: The dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 43:175-197.
18. Calíbrese, E. J., McCarthy, M. E., and Kenyon, E. 1987. The occurrence of chemically induced hormesis. Health Phys. 52:531-541.
19. Canadian Public Health Association. 1993. Benefit, risk and cost management of drugs. Report of the CPHA National Advisory Panel on Risk/Benefit Management of Drugs. Ottawa: Canadian Public Health Association. January.
20. Canadian Standards Association. 1991. CAN/CSA-Q634-91. Risk analysis requirements and guidelines, Quality management. A National Standard of Canada. Rexdale (Toronto).
21. Canadian Standards Association. 1997. CAN/CSA-Q850-97. Risk management: Guideline for decision-makers. Rexdale (Toronto).
22. Carlin, B. P., and Louis, T. A., 1996. Bayes and empirical Bayes methods for data analysis. New York: Chapman and Hall.
23. Carpy, S. A., Kobel, W., and Doe J. 2000. Health risk of low-dose pesticide mixtures: A review of the 1985-1998 literature on combination toxicology and health risk assessment. J. Toxicol. Environ. Health B 3:1-25.
24. Charles, G. D. 2004. In vitro models in endocrine disruptor screening. Inst. Lab. Anim. Res. J. 45:494-501.
25. Chen, S. 2003 TSRI #19 - To document neonatal exposure of endocrine disrupting chemicals in human amniotic fluid. Health Canada, Safe Environments. http://www.hc-sc.gc.ca/sr-sr/pubs/funding-finance/tsri-irst/sum-som/ summary-neonatal-sommaire_e.html, accessed 3 July 2007.
26. Choi, S. M., Yoo, S. D., and Lee, B. M. 2004. Toxicological characteristics of endocrine-disrupting chemicals: Developmental toxicity, carcinogenicity and mutagenicity. J. Toxicol. Environ. Health B 7:1-24.
27. Chu, I., Bowers, W. J., Caldwell, D., Nakai, J., Pulido, O., Yagminas, A., Wade, M. G., Moir, D., Gill, S., and Mueller, R. 2005. Toxicological effects of gestational and lactational exposure to a mixture of persistent organochlorines in rats: Systemic effects. Toxicol. Sci. 88:645-655.
28. Clewell, H. J., and Andersen, M. E. 1985. Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health 1:111-131.
29. Collins, W. T., and Capen, C. C. 1980 Fine structural lesions and hormonal alterations in thyroid glands of perinatal rats exposed in utero and by milk to polychlorinated biphenyls. Am. J. Pathol. 99:125-142.
30. Committee on the Environment and Natural Resources. 1996. The health and ecological effects of endocrine disrupting chemicals: A framework for planning. Committee on Environment and Natural Resources, National Science and Technology Council, Office of Science and Technology Policy. November 22, Washington, DC.
31. Cooke, A. S. 1973 Shell thinning in avian eggs by environmental pollutants. Environ. Pollut. 4:65-152.
32. Crump, K. S. 1984. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4:854-871.
33. CSTEE. 1999. Opinion on human and wildlife health effects of endocrine disrupting chemicals, with emphasis on wildlife and ecotoxicology test methods. CSTEE: Brussels.
34. Daston, G. P., Cook, J. C., and Kavlock, R. J. 2003. Uncertainties for endocrine disrupters: Our view on progress. Forum. Toxicol. Sci. 74:245-252.
35. DeRosa, C., Richter, P., Pohl, H., and Jones, D. E. 1998. Environmental exposures that affect the endocrine system: Public health implications. J. Toxicol. Environ. Health B 1:3-26.
36. DeRosa, C. T., El-Masri, H. A., Pohl, H., Cibulas, W., and Mumtaz, M. M. 2004. Implications of chemical mixtures in public health practice. J. Toxicol. Environ. Health B 7:339-350.
37. Dewailly, E., Ayotte, P., Laliberté, C., Weber, J.-P, Gingras, S., and Nantel, A. J. 1996. Polychlorinated biphenyl (PCB) and dichlorodiphenyl dichloroethylene (DDE) concentrations in the breast milk of women in Quebec. Am. J. Public Health 86:1241-1246.
38. Dodds, E. C., and Lawson, W. 1938. Molecular structure in relations to oestrogenic activity. Compounds without a phenanthrene nucleus. Proc. R. Soc. Lond. 125:222-232.
39. EDSTAC. 1998. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) final report. U.S. Environmental Protection Agency. Washington, DC.
40. EM-COM. 2003. The information site on endocine disruption. www.emcom.ca. Accessed March 20, 2007.
41. Engel, S. M., Levy, B., Liu, Z., Kaplan, D., and Wolff, M. S. 2006. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod. Toxicol. 21:110-112.
42. Environment Canada. 1999. Endocrine disrupting substances in the environment. Fact Sheet. http://www.ec.gc.ca/eds/fact/index.htm. Accessed 3 July 2007.
43. U.S. Environmental Protection Agency. 2002. EPA statement regarding endocrine disruptor low-dose hypothesis. http://www.epa.gov/scipoly/ oscpendo/docs/edmvs/lowdosepolicy.pdf. Accessed 26 March 2002.
44. European Commission. 2000. Towards the establishment of a priority list of substances for further evaluation of their role in endocrine disruption. BKH Consulting Engineers, Delft, The Netherlands in association with TNO Nutrition and Food Research, Zeist, The Netherlands.
45. European Commission. 1999. Communication from the Commission to the Council and the European parliament, Community strategy for endocrine disrupters, a range of substances suspected of interfering with the hormone systems of humans and wildlife. (COM (1999)706). Commission of the European communities. Brussels, 17.12.1999.
46. Evans, B. A., Griffiths, K., and Morton, M. S. 1995. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 147:295-302.
47. Fenske, R. A., Lu, C., Simcox N. J., Lowewenherz, C., Touchstone, J., Moate, T. F., Allen, E. H., and Kissel, J. C. 2000. Strategies for assessing children's organophosphate pesticide exposures in agricultural communities. J. Exp. Anal. Environ. Epidemiol. 10:662-671.
48. Fisher, J. S. 2004. Are all EAC effects mediated via steroid hormone receptors? Toxicology 205:33-41.
49. Fletcher, R. J. 2003. Food sources of phyto-oestrogens and their precursors in Europe. Br. J. Nutr. 89(Suppl. 1):S39-S43.
50. Food Quality Protection Act. 1996. http://www.epa.gov/pesticides/ regulating/laws/fqpa Accessed 3 July 2007.
51. Foster W. G., and Agazarian J. 2008. Toward less confusing terminology in endocrine disruptor research. J. Toxicol. Environ. Health B, 11: in press.
52. Foster, W. G., Chan, S., Platt, L., and Hughes, C. L., Jr. 2002. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol. Lett. 129:199-205.
53. Foster, W., Chan, S., Platt, L., and Hughes, C. 2000 Detection of endocrine disrupting chemicals in samples of second trimester human amniotic fluid. J. Clin. Endocrinol. Metab. 85:2954-2957.
54. Francois, E., Wang, D.-Y, Fulthorpe, R., Liss, S., and Edwards, E. A. 2003. DNA microarrays for detecting endocrine-disrupting compounds Biotechnol. Adv. 22:17-26.
55. Gaido, K. W., Leonard, L. S., Maness, S. C., Hall, J. M., McDonnell, D. P., Saville, B., and Safe, S. 1999. Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology 140:5746-5753.
56. Gaylor, D. W. 1989. Quantitative risk analysis for quantal reproductive and developmental effects. Environ. Health Perspect. 79:243-246.
57. Gaylor, D. W. 1992. Incidence of developmental effects at the no observed effect level (NOAEL). Regul. Toxicol. Pharmacol. 15:151-160.
58. Gaylor, D. W., Ryan, L., Krewski, D., and Zhu, Y. 1998. Procedures for calculating benchmark doses for health risk assessment. Regul. Toxicol. Pharmacol. 28:150-164.
59. Gelman, A., Bois, F., and Jiang, J. 1996. Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J. Am. Stat. Assoc. 91:1400-1412.
60. Goldman, L. R., Anton-Culver, H., Kharrazi M., and Blake, E. 1995. Banking of human tissue for biomonitoring and exposure assessment: Utility for environmental epidemiology and surveillance. Environ. Health Perspect. 103(Suppl, 3):31-34.
61. Gorski, R. A. 1996. Androgens and sexual differentiation of the brain. In Pharmacology, biology and clinical applications of androgens, ed. A. Bhasin, pp. 159-168. New York:Wiley-Liss.
62. Gould, R. W. 1972. Brown pelican eggshells: X-ray diffraction studies. Bull. Environ. Contam. Toxicol. 8:84-88.
63. Gray, L. E., Ostby, J., Cooper, R. L., and Kelce, W. R. 1999. The estrogenic and antiandrogenic pesticide methoxychlor alters the reproductive tract and behavior without affecting pituitary size or LH and prolactin secretion in male rats. Toxicol. Ind. Health 15:37-47.
64. Gray, L. E., and Ostby, J. S. 1998. Effects of pesticides and toxic substances on behavioral and morphological reproductive development: Endocrine versus non-endocrine mechanisms. Toxicol. Ind. Health 14:159-184.
65. Gray, L. E., Kelce, W. R., Wiese, T., Tyl, R., Gaido, K., Cook, J., Klinefelter, G., Desaulniers, D., Wilson, E., Zacharewski, T., Waller, C., Foster, P., Laskey, J., Reel, J., Giesy, J., Laws, S., McLachlan, J., Breslin, W., Cooper, R., Di Giulio, R., Johnson. R., Purdy, R., Mihaich, E., Safe, S., Sonnenschein, S., Welshons, W., Miller, R., McMaster, S., and Colborn, T. 1997. Endocrine Screening Methods Workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod. Toxicol. 11:719-750.
66. Gray, L. E., Ostby, J. S., and Kelce, W. R. 1994. Developmental effects of an environmental antiandrogen: The fungicide vinclozolin alters sex differentiation of the male rats. Toxicol. Appl. Pharmacol. 129:46-52.
67. Gray, L. E., Ostby, J., Marshall, R., and Andrews, J. 1993. Reproductive and thyroid effects of low-level polychlorinated biphenyl (Aroclor 1254) exposure. Fundam. Appl. Toxicol. 20:288-294.
68. Greenland, S. 1994. Invited commentary: A critical look at some popular meta-analytic methods. Am. J. Epidemiol. 140:290-296.
69. Hadley, M. E. 1996. Endocrinology, 4th ed. Upper Saddle River, NJ: Prentice Hall.
70. Hankinson, O. 1995. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:307-340.
71. Harvey, P. W., and Johnson, I. 2002. Approaches to the assessment of toxicity data with endpoints related to endocrine disruption. J. Appl. Toxicol. 22:241-247.
72. Health and Welfare Canada. 1990. Health risk determination: The challenge of health protection. Ottawa: Health and Welfare Canada.
73. Health Canada. 1993. Health risk determination: The challenge of health protection. Ottawa: Health Protection Branch.
74. Hiroi, H., Tsutsumi, O., Momoeda, M., Takai, Y., Osuga, Y., and Taketani, Y. 1999. Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta. Endocr. J. 46:773-778.
75. Hirsch, K. S., Weaver, D. E., Black, L. J., Falcone, J. F., and MacLusky, N. J. 1987 Inhibition of central nervous system aromatase activity: A mechanism for fenarimol-induced infertility in the male rat. Toxicol. Appl. Pharmacol. 91:235-245.
76. Holloway, A. C., Stys, K. A., and Foster, W. G. 2005. DDE-induced changes in aromatase activity in endometrial stromal cells in culture. Endocrine 27:45-50.
77. Hong, H., Tong, W., Fang, H., Shi, L., Xie, Q., Wu, J., Perkins, R., Walker, J.D., Branham, W., and Sheehan, D. M. 2002. Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree based model with structural alerts. Environ. Health Perspect. 110:29-36.
78. Hrudey, S. E., and Leiss, W. 2003. Risk management and the precaution: Insights on the cautious use of evidence. Environ. Health Perspect. 111:1577-1581.
79. Huisman, M., Koopman-Esseboom, C., Lanting, C. I., van der Paauw, C., Tuinstra, L. G. M., Fidler, V., Weisglas-Kuperus, N., Sauer, P. J. J., Boersma, E. R., and Touwen, B. C. L. 1995 Neurological condition in 18-months-old children perinatally exposed to polychlorinated biphenyls and dioxins. Early Human Dev. 43:165-176.
80. Ikezuki, Y., Tsutsumi, O., Takai, Y., Kamei, Y., and Taketani, Y. 2002. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 17:2839-2841.
81. ILSI Risk Science Institute. 1998. Assessing the toxicity of exposure to mixtures of disinfection by-products: Research recommendations. Expert Working Group on Mixtures of Disinfection By-products. Washington, DC: ILSI Risk Science Institute.
82. Imperato-McGinley, J., Sanchez, R. S., Spencer, J. R., Yee, B., and Vaughan, E. D. 1992. Comparison of the effects of the 5α-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: Dose-response studies. Endocrinology 131:1149-1156.
83. International Programme on Chemical Safety. 2002. Global assessment of the state of the science of endocrine disrupters. eds. Damstra, T. Barlow, S., Bergman, A., Kavlock, R., and Van Der Kraak, G. Geneva: World Health organization. http://www.who.int/ipcs/publications/new_issues/ endocrine_disruptors/en. Accessed 3 July 2007.
84. Isaac, D. D., and Andrew, D. J. 1996. Tubulogenesis in Drosophila: A requirement for the trachealess gene product. Genes Dev. 10:103-117.
85. Jacobson, J. L., and Jacobson, S. W. 1996. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N. Engl. J. Med. 335:783-789.
86. Jacobson, J. L., Jacobson, S. W., and Humphrey, H. E. B. 1990. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J. Pediatr. 116:38-45.
87. Janosek, J., Hilscherova, K., Blaha, L., and Holoubek, I. 2006. Environmental xenobiotics and nuclear receptors - Interactions, effects and in vitro assessment. Toxicol. In Vitro 20:18-37.
88. Jardine, C., Hrudey, S., Shortreed, J., Craig, L., Krewski, D,. Furgal, C., and McColl, S. 2003. Risk management frameworks for human health and environmental risks. J. Toxicol. Environ. Health B 6:569-720.
89. Jarrell, J. F., Milleneuve, D., Franklin, C., Bartlett, S., Wrixon, W., Kohut, J., and Zouves, C. G. 1993. Contamination of human ovarian follicular fluid and serum by chlorinated organic compounds in three Canadian cities. Can. Med. Assoc. J. 148:1321-1327.
90. Jöels, M. 2006. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol. Sci. 27 :244-250.
91. Jones, D. R. 1992. Meta-analysis of observational epidemiological studies: A review. J. R. Soc. Med. 85:165-168.
92. Kao, Y. C., Zhou, C., Sherman, M., Laughton, C. A., and Chen, S. 1998. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ. Health Perspect. 106:85-92.
93. Kavlock, R. J., Daston, G. P., DeRosa, C., Fenner-Crisp, P., Gray, L. E., Kaattari, S., Lucier, G., Luster, M., Mac, M. J., Maczka, C., Miller, R., Moore, J., Rolland, R., Scott, G., Sheehan, D. M., Sinks, T., and Tilson, H. A. 1996. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the US EPA Sponsored Workshop. Environ. Health Perspect. 104(Suppl. 4):715-740.
94. Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., and Wilson, E. M. 1995. The persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375:581-585.
95. Kelce, W. R., Lambright, C., Gray, L. E., and Roberts, K. 1997. Vinclozolin and p,p′-DDE alter androgen-dependent gene expression: In vivo confirmation of an androgen receptor mediated mechanism. Toxicol. Appl. Pharmacol. 142:192-200.
96. Kodell, R. L., Chen, J. J., Delongchamp, R. R., and Young, J. F. 2006. Hierarchical models for probabilistic dose-response assessment. Regul. Toxicol. Pharmacol. 45:265-272.
97. Koopman-Esseboom, C., Weisglas-Kuperus, N., de Riddert, M. A. J., van der Paauw, C. G., Tuinstra, L. G. M. T., and Sauer, P. J. J. 1996. Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants' mental and psychomotor development. Pediatrics 97:700-706.
98. Krewski, D., Smythe, R., and Fung, K. Y. 2002. Optimal designs for estimating the effective dose in developmental toxicity experiments. Risk Anal. 22:1195-1205.
99. Krewski, D., Zhu, Y., and Fung, K. Y. 1999. Benchmark doses for developmental toxicants. Inhal. Toxicol. 11:579-592.
100. Krewski, D., Withey, J. R., Ku, L. F., and Andersen, M. E. 1994. Applications of physiologic pharmacokinetic modelling in carcinogenic risk assessment. Environ. Health Perspect. 102:(Suppl. 11):37-50.
101. Krewski, D., and Birkwood, P. 1986. Structured approaches to risk assessment and risk management. In Conceptual trends and implications for risk assessment, pp. 149-167. Collaborative Paper CP-86-26. Vienna: Institute for Applied Systems Analysis.
102. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. A. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252-4263.
103. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. 1996. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93:5925-5930.
104. LaKind, J. S., and Berlin, C. M., Jr. 2002. Technical workshop on human milk surveillance and research on environmental chemicals in the United States: An overview. J. Toxicol. Environ. Health A 65:1829-1837.
105. Landi, M. T., Consonni, D., Patterson, D. G., Jr., Needham, L. L., Lucier, G., Brambilla, P., Cazzaniga, M. A., Mocarelli, P., Pesatori, A. C., Bertazzi, P. A., and Caporaso, N. E. 1998. 2,3,7,8-Tetrachlorodibenzo-p-dioxin plasma levels in Seveso 20 years after the accident. Environ. Health Perspect. 106:273-277.
106. Landrigan, P., Garg, A., and Droller, D. B. J. 2003. Assessing the effects of endocrine disruptors in the National Children's Study. Environ. Health Perspect. 111:1678-1682.
107. Lephart, E. D., and Simpson, E. R. 1991. Assay of aromatase activity. Methods Enzymol. 206:477-483.
108. Leung, G. P., Cheng-Chew, S. B., and Wong, P. Y. 2001. Nongenomic effect of testosterone on chloride secretion in cultured rat efferent duct epithelia. Am. J. Physiol. Cell. Physiol. 280:C1160-C1167.
109. Links, J. M., Kensler, T. W., and Groopman, J. D. 1995. Biomarkers and mechanistic approaches in environmental epidemiology. Annu. Rev. Public Health 16:83-103.
110. Luconi, M., Bonaccorsi, L., Forti, G., and Baldi, E. 2001. Effects of estrogenic compounds on human spermatozoa: Evidence for interaction with a nongenomic receptor for estrogen on human sperm membrane. Mol. Cell. Endocrinol. 178:39-45.
111. Magnusdottir, E. V., Thorsteinsson, T., Thorsteinsdottir, S., Heimisdottir, M., and Olafsdottir, K. 2005. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum. Reprod. 20:208-215.
112. Makela, S., Poutanen, M., Kostian, M. L., Lehtimaki, N., Strauss, L., Santti, R., and Vihko, R. 1998. Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc. Soc. Exp. Biol. Med. 217:310-316.
113. Makri, A., Goveia, M., Balbus, J., and Parkin, R. 2004. Children's susceptibility to chemicals: A review by developmental stage. J. Toxicol. Environ. Health B 7:417-435.
114. Maness, S. C., McDonnell, D. P., and Gaido, K. W. 1998. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells. Toxicol. Appl. Pharmacol. 151:135-142.
115. McCarty, L. S., and Borgert, C. J. 2006. Review of the toxicity of chemical mixtures: Theory, policy, and regulatory practice. Regul. Toxicol. Pharmacol. 45:119-143.
116. McKinney, J. D., and Waller, C. L. 1998. Molecular determinants of hormone mimcry: Halogenated aromatic hydrocarbon environmental agents. J. Toxicol. Environ. Health B 1:27-58.
117. Meeker, J. D., Barr, D. B., Ryan, L., Herrick, R. F., Bennett, D. H., Bravo, R., and Hauser, R. 2005. Temporal variability of urinary levels of nonpersistent insecticides in adult men. J. Exp. Anal. Environ. Epidemiol. 15:271-281.
118. Meewen, B. S., and Alves, S. E. 1999. Estrogen actions in the central nervous system. Endocr. Rev. 20:279-307.
119. Melnick, R., Lucier, G., Wolfe, M., Hall, R., Stancel, G., Prins, G., Gallo, M., Reuhl, K., Ho, S. M., Brown, T., Moore, J., Leakey, J., Haseman, J., and Kohn, M. 2002. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ. Health Perspect. 110:427-431.
120. Michalek, J. E., Ketchum, N. S., and Check, I. J. 1999. Serum dioxin and immunologic response in veterans of Operation Ranch Hand. Am. J. Epidemiol. 149:1038-1046.
121. Mocarelli, P., Brambilla, P., Gerthoux, P. M., Patterson, D. G., Jr., and Needham, L.L. 1996. Change in sex ratio with exposure to dioxin. Lancet 348:409.
122. Mocarelli, P., Gerthoux, P. M., Ferrari, E., Jr., Patterson, D. G., Kieszak, S. M., Brambilla, P., Vincoli, N., Signorini, S., Tramacere, P., Carreri, V., Sampson, E. J., and Turner, W. E. 2000. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 355:1858-1863.
123. Moriyama, K., Tagami, T., Akamizu, T., Usui, T., Saijo, M., Kanamoto, N., Hataya, Y., Shimatsu, A., Kuzuya, H., and Nakao, K. 2002. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J. Clin. Endocrinol. Metab. 8711:5185-5190.
124. Mosselman, S., Polman, J., and Dijkema, R. 1996. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 392:49-53.
125. Mosteller, F., and Colditz, G. A. 1996. Understanding research synthesis (meta-analysis). Annu. Rev. Public Health 17:1-23.
126. Naciff, J. M., Jump, M. L., Torontali, S. M., Carr, G. J., Tiesman, J. P., Overmann, G. J., and Daston, G. P. 2002. Gene expression profile induced by 17α-ethynyl estradiol, bisphenol A and genistein in the developing female reproductive system of the rat. Toxicol. Sci. 68:184-199.
127. Naciff, J. M., Overmann, G. J., Torontali, S. M., Carr, G. J., Tiesman, J. P., Richardson, B. D., and Daston, G. P. 2003. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol. Sci. 72:314-330.
128. Naciff, J. M., and Daston, G. P. 2004. Toxicogenomic approach to endocrine disrupters: Identification of a transcript profile characteristic of chemicals with estrogenic activity. Toxicol. Pathol. 32(Suppl. 2):59-70.
129. Nambu, M., Watanabe, H., Kim, K. M., Tanaka, M., Mayumi, M., and Mikawa, H. 1991. Regulation of Fc gamma receptor subtype expression on a human eosinophilic leukemia cell line EoL-3: Participation of cAMP and protein kinase C in the effects of interferon-gamma and phorbol ester. Cell. Immunol. 133:27-40.
130. National Research Council. 1999. Hormonally active agents in the environment. Chapter 3: Exposures: sources and dynamics of hormonally active agents in the environment. National Academy Press. www.nap.edu/openbook/ 0309064198/html. Accessed 3 July 2007.
131. National Research Council. 1983. Risk assessment in the federal government: Managing the process. Committee on the Institutional Means for Assessment of Risks to Public Health. Commission on Life Sciences. Washington, DC: National Academy Press.
132. Needham, L. L., and Sexton, K. 2000. Assessing children's exposure to hazardous environmental chemicals: An overview of selected research challenges and complexities. Introduction and overview. J. Exp. Anal. Environ. Epidemiol. 10:611-629.
133. NHANES. 2003-2004. National Health and Nutrition Examination Survey. Centers for Disease Control (CDC). http://www.cdc.gov/nchs/about/major/nhanes/ nhanes2003-2004/nhanes03_04.htm. Accessed 3 July 2007.
134. Northern Contaminants Program. 2003. Human health: Canadian Arctic contaminants assessment report II. Indian and Northern Affairs Canada. http://www.ainc-inac.gc.ca/ncp/pub/heltsum_e.html. Accessed 17 February 2008.
135. O'Connor, J. C., Cook, J. C., Marty, M. S., Davis, L. G., Kaplan, A. M., and Carney, E. M. 2002. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs). Crit. Rev. Toxicol. 32:521-549.
136. Ohlsson, A. 1994. Systematic reviews - Theory and practice. Scand. J. Clin. Lab. Invest. Suppl 219:25-32.
137. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., Yanagisawa, J., Fujii-Kuriyama, Y., and Kato, S. 2003. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423:545-550.
138. Okey, A. B., Riddick, D. S., and Harper, P. A. 1994. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70:1-22.
139. Olsen, N. J., and Kovacs, W. J. 1996. Gonadal steroids and immunity. Endocr. Rev. 17:369-384.
140. Ostby, J., Kelce, W. R., Lambright, C., Wolf, C. J., Mann, P., and Gray, L. E. 1999. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol. Ind. Health 15:80-93.
141. Pant, N., Mathur, N., Banerjee, A. K., Srivastava, S. P., and Saxena, D. K. 2004. Correlation of chlorinated pesticides concentration in semen with seminal vesicle and prostatic markers. Reprod. Toxicol. 19:209-214.
142. Pepper, G., Brenner, S., and Gabrilove, J. 1990. Ketoconazole use in the treatment of ovarian hyperandrogenism. Fertil. Steril. 54:38-44.
143. Peterson, R. E., Theobald, H. M., and Kimmel, G. L. 1993. Developmental and reproductive toxicity of dioxins and related compounds: Cross-species comparisons. Crit. Rev. Toxicol. 23:283-335.
144. Pflieger-Bruss, S., Schuppe, H. C., and Schill, W. B. 2004. The male reproductive system and its susceptibility to endocrine disrupting chemicals. Andrologia 36:337-345.
145. Phillips, K. P., Aronson, K. J., Brunet, P., Foster, W. G., Kacew, S., Leiss, W., Mehta, M., Poirier, R., Salem, T., Van Der Kraak, G., Wade, M. G., Walker, M., Wigle, D. T., and Krewski, D. 2003. www.emcom.ca - A risk communication vehicle about endocrine disruption. Biol. Reprod. 68(Suppl. 1):Abstr. 59.
146. Porterfield, S. P., and Hendry, L. B. 1998. Impact of PCBs on thyroid hormone directed brain development. Toxicol. Ind. Health 14:103-120.
147. Presidential and Congressional Commission on Risk Assessment and Risk Management. 1997. Risk assessment and risk management in regulatory decision-making - Final report, Volume 2. Washington DC: U.S. Government printing office. GPO 055-000-0568-1.
148. Pryor, J. L., Hughes, C., Foster, W., Hales, B. F., and Robaire, B. 2000. Critical windows of exposure for children's health: The reproductive system in animals and humans. Environ. Health Perspect. 108(Suppl. 3):491-503.
149. Quattrochi, L. C., and Tukey, R. H. 1989. The human cytochrome Cypl A2 gene contains regulatory elements repons to 3-methylcholanthrene. Mol. Pharmacol. 36:66-71.
150. Reiter, L. W., DeRosa, C., Kavlock, R. J., Lucier, G., Mac, M. J., Melillo, J., Melnick, R. L., Sinks, T., and Walton, B. 1998. The US Federal Framework for research on endocrine disruptors and an analysis of research programs supported during Fiscal Year 1996. Environ. Health Perspect. 106:105-113.
151. Revelli, A., Massobrio, M., and Tesarik, J. 1998. Nongenomic actions of steroid hormones in reproductive tissue. Endocr. Rev. 19:3-17.
152. Reynolds, P., Hurley, S. E., Goldberg, D. E., Yerabati, S., Gunier, R. B., Hertz, A., Anton-Culver, H., Bernstein, L., Deapen, D., Horn-Ross, P. L., Peel, D., Pinder, R., Ross, R. K., West, D., Wright, W. E., and Ziogas, A. 2004. Residential proximity to agricultural pesticide use and incidence of breast cancer in the California teachers study cohort. Environ. Res. 96:206-218.
153. Risk Management Framework Project Team. 2000. Health Canada Decision-Making Framework for Identifying, Accessings, and Managing Health Risks. August 2000. http://www.hc-sc.gc.ca/ahc-asc/pubs/hpfb/risk-risques_cp-pc- e.html Accessed 17 February 2008.
154. Rogers, M. D. 2003. The European Commission's white paper "Strategy for a Future Chemicals Policy": A review. Risk Anal. 23:381-388.
155. Rotchell, J. M., and Ostrander, G. K. 2003. Molecular markers of endocrine disruption in aquatic organisms. J. Toxicol. Environ. Health Part B 6:453-495.
156. Roy, D., Palangat, M., Chen, C.-W., Thomas, R. D., Colerangle, J., Atkinson, A. and Yan, Z.-J. 1997. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J. Toxicol. Environ. Health 50:1-29.
157. Rozati, R., Reddy, P. P., Reddanna, P., and Mujtaba, R. 2002. Role of environmental estrogens in the deterioration of male factor fertility. Fertil. Steril. 78:1187-1194.
158. Safe, S., Connor, K., Ramamoorthy, K., Gaido, K., and Maness, S. 1997. Human exposure to endocrine-active chemicals: Hazard assessment problems. Regul. Toxicol. Pharmacol. 26:52-58.
159. Safe, S., and Krishnan, V. 1995. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch. Toxicol. Suppl. 17:99-115.
160. Safe Drinking Water Amendments. 1996. http://www.epa.gov/safewater/sdwa/ laws_statutes.html. Accessed 3 July 2007.
161. Sanderson, J. T., Boerma, J., Lansbergen, G. W., and van den Berg, M. 2002. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol. Appl. Pharmacol. 182:44-54.
162. Sanderson, J. T., Letcher, R. J., Heneweer, M., Giesy, J. P., and van den Berg, M. 2001. Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes. Environ. Health Perspect. 109:1027-1031.
163. Sanderson, J. T., Seinen, W., Giesy, J. P., and van den Berg, M. 2000. 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: A novel mechanism for estrogenicity? Toxicol. Sci. 54:121-127.
164. Schantz, S. L. 1996. Developmental neurotoxicity of PCBs: What do we know and where do we go from here? Neurotoxicol. Teratol. 18:217-227.
165. Schurmeyer, T., and Nieschlag, E. 1984. Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. Acta. Endocrinol. 105:275-280.
166. Setzer, R. W., Lau, C., Mole, M. L., Copeland, M. F., Rogers, J. M., and Kavlock, R. J. 2001. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: a mathematical construct. Toxicol. Sci. 59:49-58.
167. Sharpe, R. M .1998. The roles of oestrogen in the male. Trends Endocrinol. Metab. 9:371-377.
168. Signorini, S., Gerthoux, P. M., Dassi, C., Cazzaniga, M., Brambilla, P., Vincoli, N., and Mocarelli, P. 2000. Environmental exposure to dioxin: The Seveso experience. Andrologia 32:263-270.
169. Skakkebæk, N. E., Leffers, H., Meyts, E. R. D., Carlsen, E., and Grigor, K. M. 2000. Should we watch what we eat and drink? Report of the international workshop on hormones and endocrine disrupters in food and water: Possible impact on human health, Copenhagen, Denmark, 27-30 May 2000. Trends Endocrinol. Metab. 7,:291-293.
170. Sohoni, P., and Sumpter, J. P. 1998. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158:327-339.
171. Strauss, L., Santti, R., Saarinen, N., Streng, T., Joshi, S., and Makela, S. 1998. Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol. Lett. 102-103:349-354.
172. Sylvia, V. L., Walton, J., Lopez, D., Dean, D. D., Boyan, B. D., and Schwartz, Z. 2001. 17 Beta-estradiol-BSA conjugates and 17 beta-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J. Cell. Biochem. 81:413-429.
173. Tamura, H., Maness, S. C., Reischmann, K., Dorman, D. C., Gray, L. E., and Gaido, K. W. 2001. Androgen receptor antagonism by the organophosphate insecticide fenitrothion. Toxicol. Sci. 60:56-62.
174. Thomas, K. V., Hurst, M., Matthiessen, P., and Waldock, M. J. 2001. Characterization of oestrogenic compounds in water samples collected from United Kingdom estuaries. Environ. Toxicol. Chem. 20:2165-2170.
175. Thomas, P. 1999. Nontraditional sites of endocrine disruption by chemicals on the hypothalamus-pituitary-gonadal axis: Interactions with steroid membrane receptors, monoaminergic pathways and signal transduction systems. In Endocrine disruptors: Effects on male and female reproductive systems, ed. R. K. Naz, pp. 3-38. Boca Raton, FL: CRC Press.
176. Thomas, P., and Das, S. 1997. Correlation between binding affinities of C21 steroids for the maturation-inducing steroid membrane receptor in spotted seatrout ovaries and their agonist and antagonist activities in an oocyte maturation bioassay. Biol. Reprod. 57:999-1007.
177. Tremblay, G. B., Tremblay, A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Labrie, F., and Giguere, V. 1997. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol. Endocrinol. 11:353-365.
178. United Nations Environment Program. Persistent organic pollutants (POPs) global monitoring program. http://www.chem.unep.ch/gmn/default.htm. Accessed 3 July 2007.
179. U.S. Environmental Protection Agency. 1999. Guidelines for carcinogen risk assessment. NCEA-F-0644. Washington, DC: U.S. Environmental Protection Agency.
180. U.S. Environmental Protection Agency. 1998. Research plan for endocrine disruptors. EPA/600/R-98/087. Washington DC: Office of Research and Development.
181. U.S. Environmental Protection Agency. 1997. Special report on environmental endocrine disruption: An effects assessment and analysis. EPA/630/R-96/012. Washington, DC: Office of Research and Development.
182. U.S. Environmental Protection Agency. 1991. Guidelines for developmental toxicity risk assessment. Fed. Reg. 56:63797-63826.
183. Vaal, M. A., VanLeeuwen, C. J., Hoekstra, J. A., and Hermens, J. L. M. 2000. Variation in sensitivity of aquatic species to toxicants: Practical consequences for eVect assessment of chemical substances. Environ. Manage. 25:415-423.
184. Van Tongeren, M., Nieuwenhuijsen, M. J., Gardiner, K., Armstrong, B., Vrijheid, M., Dolk, H., and Botting, B. 2002. A job-exposure matrix for potential endocrine-disrupting chemicals developed for a study into the association between maternal occupational exposure and hypospadias. Ann. Occup. Hyg. 46:465-477.
185. vom Saal, F. S., and Hughes, C. 2005. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 113:926-933.
186. Wade, M. G., Parent, S., Finnson, K. W., Foster, W., Younglai, E., McMahon, A., Cyr, D. G., and Hughes, C. 2002a. Thyroid toxicity due to subchronic exposure to a complex mixture of 16 organochlorines, lead, and cadmium. Toxicol. Sci. 67:207-218.
187. Wade, M. G., Foster, W. G., Younglai, E. V., McMahon, A., Leingartner, K., Yagminas, A., Blakey, D., Fournier, M., Desaulniers, D., and Hughes, C. L. 2002b. Effects of subchronic exposure to a complex mixture of persistent contaminants in male rats: Systemic, immune, and reproductive effects. Toxicol. Sci. 67:131-143.
188. Watson, S., and Gametch, B. 1999. Membrane-initiated steroid actions and the proteins that initiate them. Proc. Soc. Exp. Biol. Med. 220:9-19.
189. Weed, D. L. 1997. Meta-analysis under the microscope. J. Natl. Cancer Inst. 89:904-905.
190. Wiener, J. B., and Rogers, M. D. 2002. Comparing precaution in the US and Europe. J. Risk Res. 5:317-349.
191. Wessels, D., Barr, D. B., and Mendola, P. 2003. Use of biomarkers to indicate exposure to children to organophosphate pesticides: Implications for a longitudinal study of children's environmental health. Environ. Health Perspect. 111:1939-1946.
192. Williams, P. R. D., and Paustenbach, D. J. 2002, Risk characterization: principles and practice. J. Toxicol. Environ. Health B 5:337-406.
193. Wong, C., Kelce W. R., Sar, M., and Wilson, E. M. 1995. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J. Biol. Chem. 270:19998-20003.
194. Yao, T. P., Forman, B. M., Jiang, Z., Cherbas, L., Chen, J. D., and Evans, R. M. 1993. Functional ecdysone receptor is the product of EcR and ultraspiracle genes. Nature 366:476-479.
195. You, L.., Chan, S. K., Bruce, J. M., Archibeque-Engle, S., Casanova, M., Corton, J. C., and Heck, H. A. 1999. Modulation of testosterone metabolizing hepatic cytochrome (p-450) enzymes in developing Sprague-Dawley rats following in utero exposure to p,p′-DDE. Toxicol. Sci. 158:197-205.
196. You, L., Casanova, M., Archibeque-Engle, A., Sar, M., Fan, L. Q., and Heck, H. A. 1998. Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p′-DDE. Toxicol. Sci. 45:162-173.
197. Younglai, E. V., Holloway, A. C., Lim, G. E., and Foster, W. G. 2004. Synergistic effects between FSH and 1,1-dichloro-2,2-bis(p-chlo-rophenyl) ethylene (p,p′-DDE) on human granulosa cell aromatase activity. Hum. Reprod. 19:1089-1093.
198. Younglai, E. V., Foster, W. G., Hughes, E. G., Trim, K., and Jarrell, J. F. 2002. Levels of environmental contaminants in human follicular fluid, serum, and seminal plasma of couples undergoing in vitro fertilization. Arch. Environ. Contam. Toxicol. 43:121-126
199. Zoeller, R. T., Bansal, R., and Parris, C. 2005. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 146:607-612.